Items where authors include "Chesneau, J."

Article

Heymann, D. orcid.org/0000-0001-7777-0669, Ruiz-Velasco, C., Chesneau, J. et al. (3 more authors) (2016) Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic Glycosaminoglycans. Molecules, 21 (3). 309. ISSN 1420-3049

Biteau, K., Guiho, R., Chatelais, M. et al. (5 more authors) (2016) L-MTP-PE and zoledronic acid combination in osteosarcoma: pre-clinical evidence of positive therapeutic combination for clinical transfer. American Journal of Cancer Research, 6 (3). 0025208. pp. 677-689. ISSN 2156-6976

Lezot, F., Chesneau, J., Navet, B. et al. (9 more authors) (2015) Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid. BONE, 73. pp. 51-59. ISSN 8756-3282

Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282

Lamora, A., Talbot, J., Bougras, G. et al. (10 more authors) (2014) Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research, 20 (19). pp. 5097-5112. ISSN 1078-0432

Gobin, B., Battaglia, S., Lanel, R. et al. (5 more authors) (2014) NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate. Cancer Letters, 344 (2). pp. 291-298. ISSN 0304-3835

Georges, S., Chesneau, J., Hervouet, S. et al. (7 more authors) (2013) A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. European Journal of Cancer, 49 (9). pp. 2253-2263. ISSN 0959-8049

Talbot, J., Brion, R., Picarda, G. et al. (8 more authors) (2013) Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832 (4). pp. 553-564. ISSN 0925-4439

Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431

Battaglia, S., Dumoucel, S., Chesneau, J. et al. (6 more authors) (2011) Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient. Journal of Bone and Mineral Research, 26 (10). pp. 2439-2451. ISSN 0884-0431